Growth Metrics

Soleno Therapeutics (SLNO) Shares Outstanding: 2013-2019

Historic Shares Outstanding for Soleno Therapeutics (SLNO) over the last 2 years, with Sep 2019 value amounting to $31.8 million.

  • Soleno Therapeutics' Shares Outstanding rose 48.32% to $31.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $31.8 million, marking a year-over-year increase of 48.32%. This contributed to the annual value of $31.8 million for FY2018, which is 65.06% up from last year.
  • According to the latest figures from Q3 2019, Soleno Therapeutics' Shares Outstanding is $31.8 million, which was down 0.00% from $31.8 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Shares Outstanding ranged from a high of $31.8 million in Q2 2019 and a low of $2.8 million during Q4 2015.
  • In the last 3 years, Soleno Therapeutics' Shares Outstanding had a median value of $26.6 million in 2018 and averaged $26.1 million.
  • As far as peak fluctuations go, Soleno Therapeutics' Shares Outstanding tumbled by 58.58% in 2015, and later skyrocketed by 473.03% in 2017.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Shares Outstanding stood at $2.8 million in 2015, then climbed by 19.75% to $3.4 million in 2016, then spiked by 473.03% to $19.2 million in 2017, then spiked by 65.06% to $31.8 million in 2018, then spiked by 48.32% to $31.8 million in 2019.
  • Its last three reported values are $31.8 million in Q3 2019, $31.8 million for Q2 2019, and $31.8 million during Q1 2019.